The Application Notebook
Aflatoxins (B1, B2, G1, and G2) are naturally occurring mycotoxins produced by fungi on agricultural crops. They are classified as carcinogenic and can pose a significant risk to human health if consumed. Although aflatoxin B1 is the most potent carcinogen, the main concern in milk is its hydroxylated metabolite, aflatoxin M1. To ensure the safety of milk, the US FDA established a tolerance of 0.5 µg/kg for aflatoxin M1 in milk, while the EU set a limit of 0.05 µg/kg in raw milk and 0.025 µg/kg in infant formula. A simple and effective method using polymeric solid-phase extaction (SPE) and liquid chromatography coupled to tandem mass spectrometry (LC–MS–MS) is presented for the analysis of aflatoxins in milk at the low concentrations required.
Aflatoxins (B1, B2, G1, and G2) are naturally occurring mycotoxins produced by fungi on agricultural crops. They are classified as carcinogenic and can pose a significant risk to human health if consumed. Although aflatoxin B1 is the most potent carcinogen, the main concern in milk is its hydroxylated metabolite, aflatoxin M1. To ensure the safety of milk, the US FDA established a tolerance of 0.5 µg/kg for aflatoxin M1 in milk, while the EU set a limit of 0.05 µg/kg in raw milk and 0.025 µg/kg in infant formula. A simple and effective method using polymeric solid-phase extaction (SPE) and liquid chromatography coupled to tandem mass spectrometry (LC–MS–MS) is presented for the analysis of aflatoxins in milk at the low concentrations required.
Sample Preparation
1. Sample Extraction 1 (aqueous)
Whole milk (20 g) was deproteinized with glacial acetic acid (200 µL),vortexed (5 min), and centrifuged (≥ 3000 g, 5 min).
2. SPE Extraction
SPE cartridges were conditioned with methanol (3 mL) and DI water (3 mL) prior to loading of the sample supernatant (≤ 5 mL/min).
3. Sample Extraction 2 (solvent)
The residual milk solids were extracted with acetone (10 mL). After centrifugation (≥ 3000 g, 5 min), the supernatant was transferred to a polypropylene centrifuge tube and the acetone removed by evaporation (50 °C, N2). The sample was dissolved in DI water (10 mL) and then applied to the same SPE cartridge used in step 2.
4. Wash Cartridge
The SPE cartridge was washed with DI water (3 mL), 50% methanol (3 mL) and dried under vacuum (≥10 inHg) for 10 min. The SPE cartridge was then washed with hexane (3 mL) and dried under vacuum (≥10 inHg) for 2 min.
5. Elution
The aflatoxins were eluted with acetone (4 mL), evaporated to dryness (50 °C, N2) and reconstituted in 1 mL of 50% methanol. Finally, the extracts were filtered with a 0.22-µm nylon syringe filter into an autosampler vial.
Analysis
Samples were analyzed on a Thermo ScientificTM DionexTM UltimateTM 3000 HPLC system coupled to a TSQ VantageTM triple quadrupole MS operated in ESI+ mode. The analytical column was a UCT Selectra C18. Samples were run using a gradient mobile phase of acidified water and acidified methanol.
Figure 1: Chromatogram of extracted milk sample at 0.5 µg/kg.
Results
Conclusions
Whole milk was spiked at two concentration levels (0.025 and 0.5 µg/kg). Matrix-matched calibration curves (0.01–2 µg/kg) were used for quantitation. Linearity was ≥ 0.995. Excellent recovery (84–100%) and repeatability (< 8%) were obtained using the presented method. Extraction with an organic solvent was found to be necessary to obtain good extraction efficiency for the aflatoxins.
UCT, LLC
2731 Bartram Road, Bristol, PA 19007, USA
Tel: (800) 385-3153 Email: methods@unitedchem.com
Website: www.unitedchem.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.